Histological Classification (WHO)
According to the WHO histological classification, lung tumors are divided into main histological types and their variants. The following groups are distinguished:
- Squamous cell carcinoma. Includes papillary, clear cell, small cell, and basaloid variants. When examining a micro-slide of a well-differentiated keratinizing squamous cell carcinoma using the immunoperoxidase method, a specific diagnostic feature is revealed: the presence of pancytokeratins in the cancer cells.
- Small cell carcinoma. Includes combined small cell carcinoma.
- Adenocarcinoma. Includes acinar, papillary, solid adenocarcinoma with mucin production, and mixed subtypes. Bronchioloalveolar carcinoma is distinguished separately, with variants including non-mucinous, mucinous, and mixed forms.
- Adenosquamous carcinoma.
- Sarcomatoid carcinoma. Unites pleomorphic, spindle cell, and giant cell carcinomas, as well as carcinosarcoma and pulmonary blastoma.
- Carcinoid tumors. Divided into typical and atypical carcinoids.
- Salivary gland-type tumors. Include mucoepidermoid, adenoid cystic, and epithelial-myoepithelial carcinomas.
Precancerous Lesions and Early Diagnosis
The classification also strictly identifies precancerous (preinvasive) lesions of the lung tissue. These include:
- Squamous cell carcinoma in situ;
- Atypical adenomatous hyperplasia;
- Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.
Instrumental methods are used for the early diagnosis of lung cancer. The primary methods are radiography and transthoracic core-needle lung biopsy, which provides cellular material for accurate histological analysis.
Features of Peripheral Lung Cancer
Peripheral lung cancer differs by having significantly greater histological diversity compared to central lung cancer. This is due to the specifics of its histogenesis. The tumor is associated not only with bronchial and bronchiolar cells (basal, goblet, ciliated), but also involves Clara cells and type II alveolar cells.
Among the histological types of peripheral cancer, glandular carcinomas (adenocarcinomas) overwhelmingly predominate. Bronchioloalveolar carcinoma is also frequently encountered. Squamous cell and small cell carcinomas rarely develop at a peripheral site.
Complications and Pathways of Metastasis
Tumor progression leads to serious local complications. The neoplasm may invade the pleural cavity, clinically causing serosanguinous or hemorrhagic pleuritis. Extension of the tumor into major bronchi, along with necrosis and abscess formation within the tumor mass, is also observed.
Lung cancer metastasizes via two main pathways:
- Lymphatic pathway. Predominates in the early stages of the disease. The first metastases appear in regional lymph nodes. In later stages, bifurcation, paratracheal, mediastinal, and cervical lymph nodes are affected. Total carcinomatosis of the lungs, pleura, and peritoneum may develop.
- Hematogenous pathway. Characteristic of later stages. Tumor cells are disseminated via the bloodstream, and metastases are found in the liver, bones, adrenal glands, and brain.